
AVITA Medical Inc
NASDAQ:RCEL

Intrinsic Value
The intrinsic value of one
RCEL
stock under the Base Case scenario is
32.05
USD.
Compared to the current market price of 5.62 USD,
AVITA Medical Inc
is
Undervalued by 82%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
AVITA Medical Inc
Fundamental Analysis


Revenue & Expenses Breakdown
AVITA Medical Inc
Balance Sheet Decomposition
AVITA Medical Inc
Current Assets | 48m |
Cash & Short-Term Investments | 25.8m |
Receivables | 12m |
Other Current Assets | 10.1m |
Non-Current Assets | 21.6m |
PP&E | 13.3m |
Intangibles | 5.4m |
Other Non-Current Assets | 2.9m |
Free Cash Flow Analysis
AVITA Medical Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
AVITA Medical Inc
Revenue
|
71.7m
USD
|
Cost of Revenue
|
-9.7m
USD
|
Gross Profit
|
62m
USD
|
Operating Expenses
|
-112.5m
USD
|
Operating Income
|
-50.6m
USD
|
Other Expenses
|
-6.5m
USD
|
Net Income
|
-57m
USD
|
RCEL Profitability Score
Profitability Due Diligence
AVITA Medical Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Score
AVITA Medical Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
RCEL Solvency Score
Solvency Due Diligence
AVITA Medical Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Score
AVITA Medical Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RCEL Price Targets Summary
AVITA Medical Inc
According to Wall Street analysts, the average 1-year price target for
RCEL
is 17.85 USD
with a low forecast of 14.14 USD and a high forecast of 23.1 USD.
Dividends
Current shareholder yield for RCEL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RCEL
stock under the Base Case scenario is
32.05
USD.
Compared to the current market price of 5.62 USD,
AVITA Medical Inc
is
Undervalued by 82%.